Market cap
₹26 Cr
Revenue (TTM)
₹17 Cr
P/E Ratio
532.3
P/B Ratio
3.4
Div. Yield
0 %
| Hipolin | Pee Cee Cosma Sope | Cupid | Gillette India | Emami | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
26 | 115 | 48,657 | 23,090 | 17,741 |
Revenue (₹ Cr) |
17 | 183 | 579 | 3,211 | 4,204 |
Net Profit (₹ Cr) |
0.05 | 10.53 | 169.47 | 683.52 | 749.11 |
Net Margin (%) |
0.29 | 5.75 | 28.13 | 21.11 | 17.47 |
RoE (%) |
-0.02 | 17.72 | 33.44 | 67.68 | 25.77 |
Price to Earnings |
532.26 | 10.93 | 287.11 | 33.78 | 23.84 |
Price-To-Book |
3.44 | 1.94 | 86.44 | 21.51 | 6.71 |
Income Statement (₹ Cr)
| Hipolin | Pee Cee Cosma Sope | Cupid | Gillette India | Emami | |
|---|---|---|---|---|---|
|
Operating Revenue
|
21.56 | 140.59 | 183.52 | 2,633.08 | 3,809.19 |
|
Total Income
|
21.93 | 142.33 | 203.18 | 2,659.18 | 3,877.30 |
|
Total Expenditure
|
24.86 | 127.57 | 141.80 | 2,001.68 | 2,784.08 |
|
EBITDA
|
-3.29 | 13.02 | 41.73 | 631.40 | 1,025.11 |
|
Depreciation
|
0.09 | 1.63 | 4.48 | 82.64 | 178.21 |
|
EBIT
|
-3.39 | 11.38 | 37.25 | 548.76 | 846.90 |
|
Interest
|
0.26 | 0.22 | 2.05 | 12.61 | 9.34 |
|
Other Income
|
0.37 | 1.74 | 19.66 | 26.10 | 68.11 |
|
Exceptional Items
|
-- | -- | -- | -- | -5.90 |
|
Profit before Tax
|
-3.28 | 12.91 | 54.86 | 562.25 | 893.86 |
|
Provision for Tax
|
-- | 3.30 | 13.97 | 150.55 | 91.12 |
|
Profit after Tax
|
-3.28 | 9.61 | 40.89 | 411.70 | 802.74 |
Liabilities (₹ Cr)
| Hipolin | Pee Cee Cosma Sope | Cupid | Gillette India | Emami | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
8.14 | 48.57 | 342.19 | 971.27 | 2,694.79 |
|
Minority Interest
|
-- | -- | -- | -- | -1.43 |
|
Non-Current Liabilities
|
0.74 | 0.40 | 8.39 | 46.97 | -463.02 |
|
Current Liabilities
|
4.09 | 8.51 | 21.20 | 759.04 | 779.35 |
|
Total Liabilities
|
12.98 | 57.81 | 371.78 | 1,830.75 | 3,525.22 |
Assets (₹ Cr)
| Hipolin | Pee Cee Cosma Sope | Cupid | Gillette India | Emami | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
8.33 | 28.76 | 89.90 | 590.67 | 1,276.03 |
|
Current Assets
|
4.65 | 28.72 | 281.88 | 1,186.61 | 1,733.66 |
|
Total Assets
|
12.98 | 57.81 | 371.78 | 1,830.75 | 3,525.22 |
|
Total Debt*
|
2.87 | 1.15 | 12.63 | 0.00 | 62.08 |
|
Net Current Assets
|
0.56 | 20.21 | 260.68 | 427.57 | 954.31 |
|
Contingent Liabilities
|
-- | 0.15 | 6.37 | 1,408.05 | 13.24 |
Cashflow (₹ Cr)
| Hipolin | Pee Cee Cosma Sope | Cupid | Gillette India | Emami | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-3.18 | 7.55 | -11.14 | 509.04 | 895.86 |
|
Cash Flow from Investing Activities
|
2.76 | -5.61 | 44.68 | -49.15 | -340.14 |
|
Cash from Financing Activities
|
0.54 | -1.44 | -1.47 | -439.90 | -499.61 |
|
Net Cash Inflow / Outflow
|
0.12 | 0.51 | 32.08 | 19.99 | 56.11 |
Ratios
Profitability Ratios
| Hipolin | Pee Cee Cosma Sope | Cupid | Gillette India | Emami | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-24.62 | 26.40 | 17.04 | 58.66 | 34.28 |
|
ROE (%)
|
-33.51 | 19.78 | 18.25 | 42.92 | 31.23 |
|
ROA (%)
|
-22.41 | 16.71 | 11.82 | 22.57 | 27.44 |
|
EBIT Margin (%)
|
-13.55 | 10.50 | 33.45 | 24.97 | 28.70 |
|
Net Margin (%)
|
-14.94 | 6.75 | 20.12 | 15.48 | 20.70 |
|
Cash Profit Margin (%)
|
-14.76 | 7.99 | 24.72 | 15.42 | 25.75 |
Growth Ratios
| Hipolin | Pee Cee Cosma Sope | Cupid | Gillette India | Emami | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
9.29 | 0.00 | 6.88 | 6.30 | 6.46 |
|
EBIT Growth (%)
|
-314.49 | 179.04 | 7.10 | 17.13 | 9.72 |
|
Net Profit Growth (%)
|
-269.88 | 0.00 | 2.59 | 15.75 | 10.86 |
|
EPS Growth (%)
|
-268.71 | 0.00 | 925.59 | 15.75 | 11.46 |
|
Book Value Growth (%)
|
-28.70 | 0.00 | 19.40 | -2.18 | 10.14 |
Valuation Ratios
| Hipolin | Pee Cee Cosma Sope | Cupid | Gillette India | Emami | |
|---|---|---|---|---|---|
|
Price / Earnings
|
0.00 | 14.66 | 8.32 | 57.34 | 31.37 |
|
Price / Book Value
|
3.33 | 2.90 | 6.97 | 24.88 | 9.39 |
|
Dividend Yield (%)
|
0.00 | 0.56 | 0.00 | 1.79 | 1.73 |
|
EV/EBITDA
|
-10.15 | 9.57 | 26.79 | 35.18 | 22.95 |
|
Market Cap (₹ Cr)
|
27.09 | 140.79 | 1,700.47 | 23,607.67 | 25,301.77 |
Solvency Ratios
| Hipolin | Pee Cee Cosma Sope | Cupid | Gillette India | Emami | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.35 | 0.02 | 0.05 | 0.00 | 0.02 |
|
Short term debt to equity ratio
|
0.26 | 0.02 | 0.04 | -- | 0.02 |
|
Current Ratio
|
1.14 | 3.38 | 13.30 | 1.56 | 2.22 |
|
Quick Ratio
|
0.82 | 1.32 | 11.33 | 1.04 | 1.83 |
|
Interest Coverage
|
-11.60 | 60.01 | 27.74 | 45.59 | 96.73 |
Operating Efficiency Ratios
| Hipolin | Pee Cee Cosma Sope | Cupid | Gillette India | Emami | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
14.07 | 0.44 | 36.53 | 10.42 | 11.85 |
|
Asset Turnover
|
1.47 | 2.45 | 0.53 | 1.76 | 1.30 |
|
Receivable days
|
56.05 | 1.60 | 114.37 | 33.84 | 45.30 |
|
Inventory Days
|
21.37 | 45.33 | 57.01 | 46.00 | 30.26 |
|
Payable days
|
54.31 | 14.91 | 6.27 | 218.60 | 136.04 |
|
Cash Conversion Cycle
|
23.11 | 32.02 | 165.11 | -138.76 | -60.48 |